Drawing for CARDIODYN

USPTO serial 79443239

CARDIODYN

Reviewed by CopyMark Law Group

Status 641Office Action
Filing date
Status date
Registration date
—
Examiner
BILLINGS, JOHN T
Law office
TMO LAW OFFICE 113

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 641: Status 641 means the USPTO mailed a non-final Office Action identifying issues with your application. You typically have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

Need help with CARDIODYN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
009Software for medical devices for assistance or supplementation of the heart; embedded software for steering cardiac medical devices; embedded software for real-time analysis of blood pressure data; software for controlling, monitoring and analyzing physiological data for medical devices; interface software for medical devices; secure programming interface software for therapeutic settings; secure control interface software for circulatory support devices; electronic sensors; embedded computer systems for medical devices; embedded biomedical data processing systems; mobile applications for monitoring patients with cardiac devices; mobile applications for remote monitoring of hemodynamic parameters; control software for mechanical heart pumps; interfaces software for ventricular assistance devices.ACTIVE—
010Implantable, invasive or external medical devices for assistance or supplementation of the heart, permanent or temporary; extracorporeal blood flow devices; ventricular assistance medical devices; extracorporeal blood circulation systems incorporating pressure sensors; artificial heart pumps; tanks, cannulas and tubes for extracorporeal blood circulation; on-board sensors for real-time detection of venous or arterial venous pressure; extracorporeal oxygenation systems; hemodynamic monitoring and control devices for patients of heart failure; membrane oxygenators integrated with blood circuits; extracorporeal circulation kits with thermal regulation; sensors for medical devices; connected blood pressure sensors; electronic apparatus for hemodynamic monitoring; computerized systems for regulating circulatory parameters; electronic systems for monitoring and controlling cardiac and circulatory functions.ACTIVE—
042Research and development services in the field of medical devices for assistance or supplementation of the heart; design, development, installation, maintenance and updating of software for medical devices; biomedical engineering services.ACTIVE—
044Services for remote monitoring of medical data for medical diagnostic and treatment purposes.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 21, 2026RFNTREFUSAL PROCESSED BY IB—
May 6, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 6, 2026RFRRREFUSAL PROCESSED BY MPU—
Mar 25, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 24, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 12, 2026DOCKASSIGNED TO EXAMINER—
Feb 15, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 15, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 12, 2026REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance